IBDEI07D ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,9648,1,4,0)
 ;;=4^190.7
 ;;^UTILITY(U,$J,358.3,9648,2)
 ;;=^267277
 ;;^UTILITY(U,$J,358.3,9649,0)
 ;;=202.81^^63^615^61
 ;;^UTILITY(U,$J,358.3,9649,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9649,1,3,0)
 ;;=3^Lymphoma,Oth Head,Face,Neck Lymphs
 ;;^UTILITY(U,$J,358.3,9649,1,4,0)
 ;;=4^202.81
 ;;^UTILITY(U,$J,358.3,9649,2)
 ;;=^267496
 ;;^UTILITY(U,$J,358.3,9650,0)
 ;;=215.9^^63^615^84
 ;;^UTILITY(U,$J,358.3,9650,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9650,1,3,0)
 ;;=3^Oth Benign Neoplasm Connect Tissue
 ;;^UTILITY(U,$J,358.3,9650,1,4,0)
 ;;=4^215.9
 ;;^UTILITY(U,$J,358.3,9650,2)
 ;;=^267620
 ;;^UTILITY(U,$J,358.3,9651,0)
 ;;=224.2^^63^615^51
 ;;^UTILITY(U,$J,358.3,9651,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9651,1,3,0)
 ;;=3^Lac Gland,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,9651,1,4,0)
 ;;=4^224.2
 ;;^UTILITY(U,$J,358.3,9651,2)
 ;;=^267672
 ;;^UTILITY(U,$J,358.3,9652,0)
 ;;=224.5^^63^615^95
 ;;^UTILITY(U,$J,358.3,9652,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9652,1,3,0)
 ;;=3^Retina,Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,9652,1,4,0)
 ;;=4^224.5
 ;;^UTILITY(U,$J,358.3,9652,2)
 ;;=^267675
 ;;^UTILITY(U,$J,358.3,9653,0)
 ;;=224.7^^63^615^28
 ;;^UTILITY(U,$J,358.3,9653,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9653,1,3,0)
 ;;=3^Duct,Sac,Nasolac Benign Neoplasm
 ;;^UTILITY(U,$J,358.3,9653,1,4,0)
 ;;=4^224.7
 ;;^UTILITY(U,$J,358.3,9653,2)
 ;;=^267677
 ;;^UTILITY(U,$J,358.3,9654,0)
 ;;=237.70^^63^615^66
 ;;^UTILITY(U,$J,358.3,9654,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9654,1,3,0)
 ;;=3^Neurofibromatosis
 ;;^UTILITY(U,$J,358.3,9654,1,4,0)
 ;;=4^237.70
 ;;^UTILITY(U,$J,358.3,9654,2)
 ;;=^278264
 ;;^UTILITY(U,$J,358.3,9655,0)
 ;;=239.6^^63^615^65
 ;;^UTILITY(U,$J,358.3,9655,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9655,1,3,0)
 ;;=3^Neoplasm,Brain,Unspec Nature
 ;;^UTILITY(U,$J,358.3,9655,1,4,0)
 ;;=4^239.6
 ;;^UTILITY(U,$J,358.3,9655,2)
 ;;=^16739
 ;;^UTILITY(U,$J,358.3,9656,0)
 ;;=239.81^^63^615^96
 ;;^UTILITY(U,$J,358.3,9656,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9656,1,3,0)
 ;;=3^Retina/Choroid Neoplasm,Unspec Nature
 ;;^UTILITY(U,$J,358.3,9656,1,4,0)
 ;;=4^239.81
 ;;^UTILITY(U,$J,358.3,9656,2)
 ;;=^338224
 ;;^UTILITY(U,$J,358.3,9657,0)
 ;;=272.0^^63^615^48
 ;;^UTILITY(U,$J,358.3,9657,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9657,1,3,0)
 ;;=3^Hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,9657,1,4,0)
 ;;=4^272.0
 ;;^UTILITY(U,$J,358.3,9657,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,9658,0)
 ;;=340.^^63^615^63
 ;;^UTILITY(U,$J,358.3,9658,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9658,1,3,0)
 ;;=3^Multiple Sclerosis
 ;;^UTILITY(U,$J,358.3,9658,1,4,0)
 ;;=4^340.
 ;;^UTILITY(U,$J,358.3,9658,2)
 ;;=^79761
 ;;^UTILITY(U,$J,358.3,9659,0)
 ;;=345.90^^63^615^29
 ;;^UTILITY(U,$J,358.3,9659,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9659,1,3,0)
 ;;=3^Epliepsy,Unspec
 ;;^UTILITY(U,$J,358.3,9659,1,4,0)
 ;;=4^345.90
 ;;^UTILITY(U,$J,358.3,9659,2)
 ;;=^268477
 ;;^UTILITY(U,$J,358.3,9660,0)
 ;;=368.02^^63^615^23
 ;;^UTILITY(U,$J,358.3,9660,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9660,1,3,0)
 ;;=3^Deprivation Amblyopia
 ;;^UTILITY(U,$J,358.3,9660,1,4,0)
 ;;=4^368.02
 ;;^UTILITY(U,$J,358.3,9660,2)
 ;;=^265361
 ;;^UTILITY(U,$J,358.3,9661,0)
 ;;=368.11^^63^615^102
 ;;^UTILITY(U,$J,358.3,9661,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9661,1,3,0)
 ;;=3^Sudden Visual Loss
 ;;^UTILITY(U,$J,358.3,9661,1,4,0)
 ;;=4^368.11
 ;;^UTILITY(U,$J,358.3,9661,2)
 ;;=^268831
 ;;^UTILITY(U,$J,358.3,9662,0)
 ;;=368.59^^63^615^11
 ;;^UTILITY(U,$J,358.3,9662,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9662,1,3,0)
 ;;=3^Color Blindness
 ;;^UTILITY(U,$J,358.3,9662,1,4,0)
 ;;=4^368.59
 ;;^UTILITY(U,$J,358.3,9662,2)
 ;;=^87408
 ;;^UTILITY(U,$J,358.3,9663,0)
 ;;=368.60^^63^615^67
 ;;^UTILITY(U,$J,358.3,9663,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9663,1,3,0)
 ;;=3^Night Blindness
 ;;^UTILITY(U,$J,358.3,9663,1,4,0)
 ;;=4^368.60
 ;;^UTILITY(U,$J,358.3,9663,2)
 ;;=^83350
 ;;^UTILITY(U,$J,358.3,9664,0)
 ;;=368.9^^63^615^113
 ;;^UTILITY(U,$J,358.3,9664,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9664,1,3,0)
 ;;=3^Visual Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,9664,1,4,0)
 ;;=4^368.9
 ;;^UTILITY(U,$J,358.3,9664,2)
 ;;=^124001
 ;;^UTILITY(U,$J,358.3,9665,0)
 ;;=369.00^^63^615^108
 ;;^UTILITY(U,$J,358.3,9665,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9665,1,3,0)
 ;;=3^Total Blindness,Both Eyes
 ;;^UTILITY(U,$J,358.3,9665,1,4,0)
 ;;=4^369.00
 ;;^UTILITY(U,$J,358.3,9665,2)
 ;;=^15310
 ;;^UTILITY(U,$J,358.3,9666,0)
 ;;=369.01^^63^615^109
 ;;^UTILITY(U,$J,358.3,9666,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9666,1,3,0)
 ;;=3^Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,9666,1,4,0)
 ;;=4^369.01
 ;;^UTILITY(U,$J,358.3,9666,2)
 ;;=^268861
 ;;^UTILITY(U,$J,358.3,9667,0)
 ;;=369.02^^63^615^75
 ;;^UTILITY(U,$J,358.3,9667,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9667,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye-NOS
 ;;^UTILITY(U,$J,358.3,9667,1,4,0)
 ;;=4^369.02
 ;;^UTILITY(U,$J,358.3,9667,2)
 ;;=^268862
 ;;^UTILITY(U,$J,358.3,9668,0)
 ;;=369.03^^63^615^74
 ;;^UTILITY(U,$J,358.3,9668,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9668,1,3,0)
 ;;=3^One Eye-Near Total/Oth Eye Total
 ;;^UTILITY(U,$J,358.3,9668,1,4,0)
 ;;=4^369.03
 ;;^UTILITY(U,$J,358.3,9668,2)
 ;;=^268863
 ;;^UTILITY(U,$J,358.3,9669,0)
 ;;=369.04^^63^615^64
 ;;^UTILITY(U,$J,358.3,9669,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9669,1,3,0)
 ;;=3^Near Total Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,9669,1,4,0)
 ;;=4^369.04
 ;;^UTILITY(U,$J,358.3,9669,2)
 ;;=^268864
 ;;^UTILITY(U,$J,358.3,9670,0)
 ;;=369.06^^63^615^77
 ;;^UTILITY(U,$J,358.3,9670,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9670,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,9670,1,4,0)
 ;;=4^369.06
 ;;^UTILITY(U,$J,358.3,9670,2)
 ;;=^268866
 ;;^UTILITY(U,$J,358.3,9671,0)
 ;;=369.07^^63^615^76
 ;;^UTILITY(U,$J,358.3,9671,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9671,1,3,0)
 ;;=3^One Eye-Profound,Oth Eye-Near
 ;;^UTILITY(U,$J,358.3,9671,1,4,0)
 ;;=4^369.07
 ;;^UTILITY(U,$J,358.3,9671,2)
 ;;=^268867
 ;;^UTILITY(U,$J,358.3,9672,0)
 ;;=369.08^^63^615^91
 ;;^UTILITY(U,$J,358.3,9672,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9672,1,3,0)
 ;;=3^Profound Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,9672,1,4,0)
 ;;=4^369.08
 ;;^UTILITY(U,$J,358.3,9672,2)
 ;;=^268868
 ;;^UTILITY(U,$J,358.3,9673,0)
 ;;=369.10^^63^615^73
 ;;^UTILITY(U,$J,358.3,9673,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9673,1,3,0)
 ;;=3^One Eye-Blind,Oth-Low Vision
 ;;^UTILITY(U,$J,358.3,9673,1,4,0)
 ;;=4^369.10
 ;;^UTILITY(U,$J,358.3,9673,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,9674,0)
 ;;=369.11^^63^615^78
 ;;^UTILITY(U,$J,358.3,9674,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9674,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Blind
 ;;^UTILITY(U,$J,358.3,9674,1,4,0)
 ;;=4^369.11
 ;;^UTILITY(U,$J,358.3,9674,2)
 ;;=^268871
 ;;^UTILITY(U,$J,358.3,9675,0)
 ;;=369.12^^63^615^81
 ;;^UTILITY(U,$J,358.3,9675,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9675,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Total
 ;;^UTILITY(U,$J,358.3,9675,1,4,0)
 ;;=4^369.12
 ;;^UTILITY(U,$J,358.3,9675,2)
 ;;=^268872
 ;;^UTILITY(U,$J,358.3,9676,0)
 ;;=369.13^^63^615^79
 ;;^UTILITY(U,$J,358.3,9676,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9676,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Near Total
 ;;^UTILITY(U,$J,358.3,9676,1,4,0)
 ;;=4^369.13
 ;;^UTILITY(U,$J,358.3,9676,2)
 ;;=^268873
 ;;^UTILITY(U,$J,358.3,9677,0)
 ;;=369.14^^63^615^80
 ;;^UTILITY(U,$J,358.3,9677,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9677,1,3,0)
 ;;=3^One Eye-Severe/Oth Eye-Profound
 ;;^UTILITY(U,$J,358.3,9677,1,4,0)
 ;;=4^369.14
 ;;^UTILITY(U,$J,358.3,9677,2)
 ;;=^268874
 ;;^UTILITY(U,$J,358.3,9678,0)
 ;;=369.22^^63^615^101
 ;;^UTILITY(U,$J,358.3,9678,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9678,1,3,0)
 ;;=3^Severe Impairment,Both Eyes
 ;;^UTILITY(U,$J,358.3,9678,1,4,0)
 ;;=4^369.22
 ;;^UTILITY(U,$J,358.3,9678,2)
 ;;=^268882
 ;;^UTILITY(U,$J,358.3,9679,0)
 ;;=369.60^^63^615^6
 ;;^UTILITY(U,$J,358.3,9679,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9679,1,3,0)
 ;;=3^Blindness,One Eye Only
 ;;^UTILITY(U,$J,358.3,9679,1,4,0)
 ;;=4^369.60
 ;;^UTILITY(U,$J,358.3,9679,2)
 ;;=^268880
 ;;^UTILITY(U,$J,358.3,9680,0)
 ;;=369.9^^63^615^114
 ;;^UTILITY(U,$J,358.3,9680,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9680,1,3,0)
 ;;=3^Visual Loss NOS
 ;;^UTILITY(U,$J,358.3,9680,1,4,0)
 ;;=4^369.9
 ;;^UTILITY(U,$J,358.3,9680,2)
 ;;=^126769
 ;;^UTILITY(U,$J,358.3,9681,0)
 ;;=377.61^^63^615^20
 ;;^UTILITY(U,$J,358.3,9681,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9681,1,3,0)
 ;;=3^D/O Pathways w/ Neoplasm
 ;;^UTILITY(U,$J,358.3,9681,1,4,0)
 ;;=4^377.61
 ;;^UTILITY(U,$J,358.3,9681,2)
 ;;=^269241
 ;;^UTILITY(U,$J,358.3,9682,0)
 ;;=379.02^^63^615^68
 ;;^UTILITY(U,$J,358.3,9682,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9682,1,3,0)
 ;;=3^Nodular Episcleritis
 ;;^UTILITY(U,$J,358.3,9682,1,4,0)
 ;;=4^379.02
 ;;^UTILITY(U,$J,358.3,9682,2)
 ;;=^269285
 ;;^UTILITY(U,$J,358.3,9683,0)
 ;;=379.07^^63^615^89
 ;;^UTILITY(U,$J,358.3,9683,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9683,1,3,0)
 ;;=3^Posterior Scleritis
 ;;^UTILITY(U,$J,358.3,9683,1,4,0)
 ;;=4^379.07
 ;;^UTILITY(U,$J,358.3,9683,2)
 ;;=^269295
 ;;^UTILITY(U,$J,358.3,9684,0)
 ;;=379.92^^63^615^105
 ;;^UTILITY(U,$J,358.3,9684,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9684,1,3,0)
 ;;=3^Swelling/Mass of Eye
 ;;^UTILITY(U,$J,358.3,9684,1,4,0)
 ;;=4^379.92
 ;;^UTILITY(U,$J,358.3,9684,2)
 ;;=^269334
 ;;^UTILITY(U,$J,358.3,9685,0)
 ;;=379.93^^63^615^93
 ;;^UTILITY(U,$J,358.3,9685,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,9685,1,3,0)
 ;;=3^Redness/Discharge of Eye
 ;;^UTILITY(U,$J,358.3,9685,1,4,0)
 ;;=4^379.93
 ;;^UTILITY(U,$J,358.3,9685,2)
 ;;=^104154
 ;;^UTILITY(U,$J,358.3,9686,0)
 ;;=379.99^^63^615^85
